Relistor

Active Ingredient(s): Methylnaltrexone Bromide
FDA Approved: * April 24, 2008
Pharm Company: * PROGENICS PHARMA
Category: Laxative

Methylnaltrexone (MNTX, brand name Relistor), used in form of methylnaltrexone bromide (INN, USAN, BAN), is a medication that acts as a peripherally acting μ-opioid receptor antagonist that acts to reverse some of the side effects of opioid drugs such as constipation without significantly affecting pain relief or precipitating withdrawals. Because MNTX is a quaternary ammonium cation, it cannot cross the blood–brain barrier, and so has antagonist effects throughout the body, counte... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Relistor 150 mg Oral Tablet
NDC: 65649-150
Labeler:
Salix Pharmaceuticals, Inc.
Relistor 12 mg/.6ml Subcutaneous Injection, Solution
NDC: 65649-551
Labeler:
Salix Pharmaceuticals, Inc.
Relistor 8 mg/.4ml Subcutaneous Injection, Solution
NDC: 65649-552
Labeler:
Salix Pharmaceuticals, Inc.
Relistor Kit
NDC: 65649-553
Labeler:
Salix Pharmaceuticals, Inc.

Popular Topics

Relistor (methylnaltrexone bromide) Reviews

I would like some feedback on Relistor 150 mg. I've been prescribed 3 pills every morning for opioid-induced or seve...

1 REPLY
Relistor

Does anyone know if there is a pill form of this drug? I am on alot of meds that cause constipation and this sounds like...